Skip to main content
Premium Trial:

Request an Annual Quote

Biolog Wins $451,000 SBIR Grant for Antimicrobial Drug-Discovery Apps on Phenotype Microarray

NEW YORK, March 1 (GenomeWeb News) - Biolog has been awarded a phase I SBIR grant from the National Institute of Allergy and Infectious Disease to further develop its Phenotype Microarray technology for antimicrobial drug discovery.

 

The $451,000 award, provided from NIAID's biodefense program of the National Institutes of Health, will fund the application of the Phenotype Microarray technology as a tool to evaluate biologically active compounds using Staphylococcus aureus as the model organism, Biolog said.

 

Scientists at Biolog will screen 150 to 200 known chemicals against the S. aureus cellular array in order to develop a database that can be subsequently used for antimicrobial evaluation, Tim Mullane, Biolog's president and CEO, told GenomeWeb News today.

 

Pharmaceutical and biotech companies could then add profiles of chemicals from their libraries to the database, the company said.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.